Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

$6.3 billion and $6.5 billion.
  • Total Actavis Specialty Brands segment revenue of between $550 million and $600 million.
  • Total Anda Distribution segment revenue of between $1.0 billion and $1.2 billion.
  • Adjusted non-GAAP earnings for 2013 is expected to be between $7.70 and $8.10 per diluted share.*
  • Adjusted EBITDA for 2013 is expected to be between $1.87 billion and $1.94 billion.*

    • *See Tables 6 and 7 and accompanying notes. 

    Webcast and Conference Call DetailsActavis will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time to discuss fourth quarter and full year 2012 results, the outlook for 2013 and recent corporate developments.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573.  The Conference ID is 94810189.

    A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 5, 2013.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 94810189.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Actavis' Investor Relations Web site at http://ir.actavis.com.  A replay of the webcast will also be available.

    About Actavis, Inc.
    Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

    Actavis is the world's third-largest generics prescription drug manufacturer.&
    '/>"/>

    SOURCE Actavis, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Watson to Acquire Actavis Group for EUR4.25 Billion
    2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
    3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
    4. Watson and Actavis Receive FTC Second Request
    5. Watson Announces New Name -- Actavis -- for Global Operations
    6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
    7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
    8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
    9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    11. Aethlon Medical Note: Fiscal Year Revenue Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)...  Viral hepatitis is an asymptomatic disease affecting more than ... hepatitis C are unaware they have the virus. ... the U.S. House of Representatives will take place at 10:00 ... Rayburn House Office Building in Washington, D.C. ... of Liver Diseases ( AASLD ) is pleased to participate ...
    (Date:5/22/2013)... WILMINGTON, Del. and MUNICH , ... venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation ... today its first interim results of the J enaValve ... Safety I n Pa T ients with S E ... Paris . JUPITER is a post-market registry ...
    (Date:5/22/2013)... 22, 2013  For the 3% of the population that ... embarrassing, uncomfortable, anxiety-inducing and disabling.  While more than half ... their symptoms, hyperhidrosis is a serious medical condition.  Finally, ... Precision TX™. Dr. Bruce Katz ... Center in New York , is ...
    Breaking Medicine Technology:Hepatitis Awareness: Bringing Attention to a Silent Epidemic 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
    ... advocacy organization , , , ... April 28 Michael W. Marine , former U.S. Ambassador ... new chief executive officer of the Sabin Vaccine Institute, announced Sabin,s Chairman of ... Hotez .  Ambassador Marine served 32 years in the U.S. State Department,s Foreign ...
    ... April 28 Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... chief executive officer, Hill-Rom.  He will be speaking at the Bank of America ... Wednesday, May 12, 2010 , at 11:20 a.m. EDT .     ... You are invited to listen to ...
    Cached Medicine Technology:Michael W. Marine Appointed CEO of Sabin Vaccine Institute 2Michael W. Marine Appointed CEO of Sabin Vaccine Institute 3Hill-Rom to Present at the Bank of America Merrill Lynch 2010 Health Care Conference 2
    (Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...
    (Date:5/22/2013)... Los Angeles, California (PRWEB) May 22, 2013 ... Report article entitled “Women Have More Options for Breast Cancer ... cancer an opportunity to approach this disease in a ... surgery has been developed, women now face breast cancer ... outcome (Go to goo.gl/ARqoN). , “Before the introduction of plastic ...
    (Date:5/22/2013)... University of Michigan study challenges previous research that ... , The study, a collaboration between researchers at ... looks deeper into the controversial argument over whether ... for pitchers of the same race. It found ... Jason Winfree, associate professor of sport management at ...
    (Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Migraines and depression ... new research indicates the combination of the two may ... brain. , , Already aware that people with migraines ... determine if having both conditions together affected total brain ... -- isn,t alarming, study authors said, but needs further ...
    (Date:5/22/2013)... Phelps Memorial Hospital Center in Sleepy ... Center for individuals who would like to be screened ... is the deadliest form of cancer for both men and ... from lung cancer than from breast, colon and prostate cancer ... survival rates. It is well established that routine mammography ...
    Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3
    ... -- A University of Michigan Health System laboratory study reveals ... could lead to a new treatment for those with sickle ... in this week,s early edition of the Proceedings of ... preventing the painful episodes and organ damage that are common ...
    ... Gordon HealthDay Reporter , TUESDAY, Nov. 1 (HealthDay ... their risk of developing cancer compared to the general population. ... cancer, according to new research. In any ... transplant is just 0.7 percent. And experts say the benefits ...
    ... Gardner HealthDay Reporter , TUESDAY, Nov. 1 ... disorder don,t appear to raise the risk of heart ... adults, new research shows. And if any ... Concerta does exist, the danger in absolute numbers would ...
    ... equation that is difficult to solve for most people, but ... transport can be an almost insurmountable task. A newly launched ... now enlisting the help of the senior citizens themselves to ... hoped that the results will lead to better urban planning. ...
    ... -- Women undergoing angioplasty, a procedure to unblock a clogged ... to new research. However, the study also shows ... an angioplasty than male patients. In conducting the study, ... Interventions , researchers analyzed information on almost 4,800 women and ...
    ... from Rhode Island Hospital examined how the perception of ... Through a web survey with embedded interventions, the researchers ... indicators of patient satisfaction, while staff reported changing or ... paper was published in the European Journal of ...
    Cached Medicine News:Health News:Researchers reveal potential treatment for sickle cell disease 2Health News:Cancer Risk Doubles After Organ Transplant, Study Finds 2Health News:Cancer Risk Doubles After Organ Transplant, Study Finds 3Health News:Little Evidence of Heart Risks From ADHD Meds 2Health News:Little Evidence of Heart Risks From ADHD Meds 3Health News:Little Evidence of Heart Risks From ADHD Meds 4Health News:Senior citizens as co-researchers to improve urban planning 2Health News:Women No More Likely to Die After Angioplasty 2Health News:How staff perceptions of their roles impact patients experience in the emergency department 2Health News:How staff perceptions of their roles impact patients experience in the emergency department 3
    ... The Bright Starlet is the world's smallest ... instrument with a choice of handwheel or lever ... is easy-to-clean and resist common decontaminating agents. An ... of the refrigeration system and to reduce frosting ...
    ... ASP300 smart tissue processor features superior user ... is a fully enclosed, stand-alone system for ... This new tissue processor combines proven technology ... screen and easy to use,yet powerful software. ...
    ... The Leica ASP200 is an advanced ... in standard and routine histopathology applications. Proven ... interface and smart operating software are the ... operations are simplified and the software includes ...
    ... microtome with automatic fine/trim- feed system, ... precision cross roller bearings. For sectioning ... in biological, botany, and materials science. ... 90 mm can be accommodated. Performance, ...
    Medicine Products: